These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30531673)

  • 1. Acyclovir Neurotoxicity in a Peritoneal Dialysis Patient: Report of a Case and Review of the Pharmacokinetics of Acyclovir.
    Sadjadi SA; Regmi S; Chau T
    Am J Case Rep; 2018 Dec; 19():1459-1462. PubMed ID: 30531673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir-Induced Neurotoxicity: A Case Report and Review of Literature.
    Chowdhury MA; Derar N; Hasan S; Hinch B; Ratnam S; Assaly R
    Am J Ther; 2016; 23(3):e941-3. PubMed ID: 24942005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurotoxicity of valacyclovir in a peritoneal dialysis patient].
    Takayanagi A; Maehana T; Kyoda Y; Yanase M
    Hinyokika Kiyo; 2010 Nov; 56(11):617-9. PubMed ID: 21187705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.
    Prasad B; McIsaac M; Toppings J
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28765478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients.
    Onuigbo MA; Nye D; Iloanya PC
    Adv Perit Dial; 2009; 25():89-91. PubMed ID: 19886325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.
    Yang HH; Hsiao YP; Shih HC; Yang JH
    Int J Dermatol; 2007 Aug; 46(8):883-4. PubMed ID: 17651180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Encephalopathy and acute renal failure during acyclovir treatment].
    Delluc A; Mocquard Y; Latour P; Goas JY
    Rev Neurol (Paris); 2004 Jul; 160(6-7):704-6. PubMed ID: 15247861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity associated with acyclovir in end stage renal failure.
    Kitching AR; Fagg D; Hay NM; Hatfield PJ; Macdonald A
    N Z Med J; 1997 May; 110(1043):167-9. PubMed ID: 9196501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of acyclovir neurotoxicity presenting with atypical cerebrospinal fluid findings.
    Thind GS; Roach R
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.
    Watson WA; Rhodes NJ; Echenique IA; Angarone MP; Scheetz MH
    J Clin Pharm Ther; 2017 Jun; 42(3):350-355. PubMed ID: 28370067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acyclovir encephalopathy in a peritoneal dialysis patient despite adjusting the dose of oral acyclovir: a case report].
    Kawabe Matsukawa M; Suzuki Y; Ikuma D; Suwabe T; Uesaka Y; Sugimoto I
    Rinsho Shinkeigaku; 2019 Dec; 59(12):834-839. PubMed ID: 31761838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis.
    Davenport A; Goel S; Mackenzie JC
    Am J Kidney Dis; 1992 Dec; 20(6):647-9. PubMed ID: 1462997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Iwasawa H; Nanri K; Yamazaki T
    Clin Nephrol; 2002 Aug; 58(2):168-70. PubMed ID: 12227692
    [No Abstract]   [Full Text] [Related]  

  • 14. Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.
    Hoskote SS; Annapureddy N; Ramesh AK; Rose K; Jones JP
    Am J Ther; 2016; 23(1):e304-6. PubMed ID: 24368610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir neurotoxicity can be effectively managed by hemodialysis.
    Kambhampati G; Pakkivenkata U; Kazory A
    Eur J Neurol; 2011 Mar; 18(3):e33. PubMed ID: 21087359
    [No Abstract]   [Full Text] [Related]  

  • 16. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
    Chaudhari D; Ginn D
    Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir-induced Neurotoxicity in a Patient with a Preserved Renal Function.
    Yoshimura T; Kawasaki T; Shirota A; Saeki M; Okada Y; Okada H
    Intern Med; 2018 Nov; 57(21):3213-3216. PubMed ID: 29877263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis.
    Stathoulopoulou F; Almond MK; Dhillon S; Raftery MJ
    Nephron; 1996; 74(2):337-41. PubMed ID: 8893152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.
    Kageyama R; Hashizume H
    J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients.
    Stathoulopoulou F; Dhillon S; Thodis H; Stathakis C; Vargemezis V
    Nephron; 2002 May; 91(1):164-6. PubMed ID: 12021536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.